title: Buying J&J Stock Ahead of Q3 Earnings? Here's What You Should Know
source: Yahoo
date: 2025-10-10
url: https://finnhub.io/api/news?id=3c17c45a6ee2eaa9d6781ef274d33e0e6f7aa80a0e08f7cac17b916900e76dad
J&J gears up for Q3 results with solid gains from Darzalex, Tremfya and MedTech, even as Stelara faces fierce biosimilar pressure.
